Education
About Us
Working with TipRanks
Follow Us
Genelux Corp. (GNLX)
NASDAQ:GNLX
Docetaxel, Olvimulogene Nanivacirepvec, Platinum Chemotherapy: Carboplatin Or Cisplatin, Non-Platinum Chemotherapy: Paclitaxel Or Nab-Paclitaxel For Squamous Cell Nsclc Or Pemetrexed For Nonsquamous Cell Nsclc, Physician's Choice Of Immune Checkpoint Inhibitor: Pembrolizumab, Nivolumab, Cemiplimab, Atezolizumab, Durvalumab
Non-small Cell Lung Cancer, Non-Small Cell Lung Cancer Stage Iv, Non-Small Cell Lung Cancer Stage Iii, Non-Small Cell Lung Cancer Recurrent, Advanced Non-Squamous Non-Small-Cell Lung Cancer, Advanced Squamous Non-Small Cell Lung Carcinoma, Metastatic Non-Squamous Non Small Cell Lung Cancer, Metastatic Squamous Non-Small Cell Lung Carcinoma
Phase II
Recruiting
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Jun 11, 2024
―
Olvimulogene Nanivacirepvec, Platinum Chemotherapy: Carboplatin (Preferred) Or Cisplatin, Non-Platinum Chemotherapy: Physician's Choice Of Gemcitabine, Taxane (Paclitaxel, Docetaxel Or Nab-Paclitaxel) Or Pegylated Liposomal Doxorubicin, Bevacizumab (Or Biosimilar)
Fallopian Tube Cancer, Platinum-Resistant Ovarian Cancer, High-Grade Serous Ovarian Cancer, Primary Peritoneal Cancer, Ovarian Clear Cell Carcinoma, Platinum-Refractory Ovarian Cancer, Endometrioid Ovarian Cancer
Phase III
Recruiting
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
Mar 07, 2022
―
Gl-Onc1
Peritoneal Carcinomatosis
Phase I/II
Completed
A Study of GL-ONC1, an Oncolytic Vaccinia Virus, in Patients With Advanced Peritoneal Carcinomatosis
Sep 20, 2011
―
Gl-Onc1
Advanced Cancers (Solid Tumors)
Phase I
Completed
Safety Study of GL-ONC1, an Oncolytic Virus, in Patients With Advanced Solid Tumors
Nov 18, 2008
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Genelux Corp. (GNLX) have in its pipeline
GNLX is currently developing the following drugs: Docetaxel, Olvimulogene Nanivacirepvec, Platinum Chemotherapy: Carboplatin Or Cisplatin, Non-Platinum Chemotherapy: Paclitaxel Or Nab-Paclitaxel For Squamous Cell Nsclc Or Pemetrexed For Nonsquamous Cell Nsclc, Physician's Choice Of Immune Checkpoint Inhibitor: Pembrolizumab, Nivolumab, Cemiplimab, Atezolizumab, Durvalumab, Olvimulogene Nanivacirepvec, Platinum Chemotherapy: Carboplatin (Preferred) Or Cisplatin, Non-Platinum Chemotherapy: Physician's Choice Of Gemcitabine, Taxane (Paclitaxel, Docetaxel Or Nab-Paclitaxel) Or Pegylated Liposomal Doxorubicin, Bevacizumab (Or Biosimilar), Gl-Onc1. These drug candidates are in various stages of clinical development as the company works toward FDA approval.